A Phase 1/2 Study Evaluating ABT-751 in Combination With Alimta in Advanced Non-Small Cell Lung Cancer
Public ClinicalTrials.gov record NCT00297089. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 1/2 Study Evaluating the Safety and Efficacy of ABT 751 in Combination With Pemetrexed Versus Pemetrexed Alone in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer
Study identification
- NCT ID
- NCT00297089
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Lead sponsor
- AbbVie (prior sponsor, Abbott)
- Industry
- Enrollment
- 165 participants
Conditions and interventions
Conditions
Interventions
- ABT-751 Drug
- pemetrexed Drug
- placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Not listed
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2006
- Primary completion
- Dec 31, 2008
- Completion
- Dec 31, 2008
- Last update posted
- Jan 30, 2013
2006 – 2009
United States locations
- U.S. sites
- 27
- U.S. states
- 19
- U.S. cities
- 26
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site Reference ID/Investigator# 3358 | Fayetteville | Arkansas | 72703 | — |
| Site Reference ID/Investigator# 4102 | Hot Springs | Arkansas | 71913 | — |
| Site Reference ID/Investigator# 2127 | Greenbrae | California | 94904 | — |
| Site Reference ID/Investigator# 2417 | Fort Collins | Colorado | 80524 | — |
| Site Reference ID/Investigator# 5690 | Torrington | Connecticut | 06790 | — |
| Site Reference ID/Investigator# 2411 | Fort Lauderdale | Florida | 33316 | — |
| Site Reference ID/Investigator# 3363 | Lakeland | Florida | 33805 | — |
| Site Reference ID/Investigator# 3352 | Port Saint Lucie | Florida | 34952 | — |
| Site Reference ID/Investigator# 3807 | Atlanta | Georgia | 30309 | — |
| Site Reference ID/Investigator# 3353 | Chicago | Illinois | 60637 | — |
| Site Reference ID/Investigator# 3359 | Indianapolis | Indiana | 46256 | — |
| Site Reference ID/Investigator# 2416 | Baltimore | Maryland | 21229 | — |
| Site Reference ID/Investigator# 2244 | Baltimore | Maryland | 21231-1000 | — |
| Site Reference ID/Investigator# 2401 | Bethesda | Maryland | 20817 | — |
| Site Reference ID/Investigator# 3793 | Peabody | Massachusetts | 01960 | — |
| Site Reference ID/Investigator# 3362 | Worcester | Massachusetts | 01608 | — |
| Site Reference ID/Investigator# 2075 | Kalamazoo | Michigan | 49048 | — |
| Site Reference ID/Investigator# 2418 | Jefferson City | Missouri | 65109 | — |
| Site Reference ID/Investigator# 4170 | St Louis | Missouri | 63110-0250 | — |
| Site Reference ID/Investigator# 3357 | Lebanon | New Hampshire | 03756 | — |
| Site Reference ID/Investigator# 5098 | Lake Success | New York | 11042 | — |
| Site Reference ID/Investigator# 2242 | Huntersville | North Carolina | 28078 | — |
| Site Reference ID/Investigator# 2413 | Columbus | Ohio | 43235 | — |
| Site Reference ID/Investigator# 3354 | Bethelem | Pennsylvania | 18015 | — |
| Site Reference ID/Investigator# 6006 | Philadelphia | Pennsylvania | 19141 | — |
| Site Reference ID/Investigator# 2414 | Bristol | Tennessee | 37620 | — |
| Site Reference ID/Investigator# 2070 | Tacoma | Washington | 98405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 21 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00297089, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 30, 2013 · Synced Apr 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00297089 live on ClinicalTrials.gov.